KPE-02003002

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameKPE-02003002

Drug Alias NameKPE-02001003KPE-02003002

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHepatitis C virus replication inhibitors

TargetsNot applicable

Therapy Area/IndicationsHepatitis C

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesKemin

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesKemin

Active IndicationsN/A

Inactive IndicationsHepatitis C

ATC CodeN/A